EDIT:NASDAQ
Editas Medicine Inc
2,17 USD
arrow_upward
+1,40%(+0,030) 1D
13. stu, 16:00:01 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EDIT...
Otvori
2,14 USD
Najviša
2,21 USD
Najniža
2,01 USD
Trž. kap.
334,92 mil.
Prosj. kol.
2,42 mil.
Količina
2,79 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Otvori
2,14 USD
Najviša
2,21 USD
Najniža
2,01 USD
Trž. kap.
334,92 mil.
Prosj. kol.
2,42 mil.
Količina
2,79 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Vijesti
Iz web-izvora i od partnera za vijesti
AP News
·
prije 1 dan
Microsoft outage shows the risks of relying on a single technology provider for essential services
Yahoo Finance
·
prije 17 sati
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
24/7 Wall St.
·
prije 8 sati
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Investor's Business Daily
·
prije 1 dan
Stock Market Falls But Nasdaq Holds Key Level; Anthropic IPO, Nvidia Earnings Loom
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc – informacije
Glavni izvršni direktor-
Zaposlenici87
Osnovanostu 2013
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijaeditasmedicine.com